LOAN AGREEMENTLoan Agreement • March 25th, 2021 • IntelGenx Technologies Corp. • Pharmaceutical preparations • New York
This LOAN AGREEMENT, dated as of March 8, 2021 (as amended, restated, modified and/or supplemented, from time to time, this "Agreement") is made by and among INTELGENX CORP. and ATAI LIFE SCIENCES AG.
STRATEGIC DEVELOPMENT AGREEMENTStrategic Development Agreement • March 25th, 2021 • IntelGenx Technologies Corp. • Pharmaceutical preparations
This Strategic Development Agreement (this "Agreement") is made and entered into as of March 14, 2021 (the "Effective Date"), by and among ATAI Life Sciences AG, a company incorporated and registered in the Federal Republic of Germany ("Atai"), and IntelGenx Corp., a Canadian corporation (the "Company"). Atai and the Company are each referred to individually as a "Party" and together as the "Parties".
PURCHASER RIGHTS AGREEMENT Between ATAI LIFE SCIENCES AG - and - INTELGENX TECHNOLOGIES CORP. March 14, 2021Purchaser Rights Agreement • March 25th, 2021 • IntelGenx Technologies Corp. • Pharmaceutical preparations • New York
WHEREAS the Company and the Purchaser have entered into a securities purchase agreement (the "Purchase Agreement") pursuant to which the Purchaser has agreed to purchase a significant interest in the Company;
SECURITIES PURCHASE AGREEMENT between ATAI LIFE SCIENCES AG - and - INTELGENX TECHNOLOGIES CORP. March 15, 2021Securities Purchase Agreement • March 25th, 2021 • IntelGenx Technologies Corp. • Pharmaceutical preparations • New York
NOW THEREFORE, in consideration of the premises and the mutual covenants and agreements herein contained and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:
